HEADER TRANSFERASE 30-AUG-23 8QE1 TITLE CRYSTAL STRUCTURE OF HUMAN MAT2A BOUND TO S-ADENOSYLMETHIONINE AND TITLE 2 COMPOUND 15 COMPND MOL_ID: 1; COMPND 2 MOLECULE: S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FULL LENGTH PROTEIN; COMPND 5 SYNONYM: ADOMET SYNTHASE 2,METHIONINE ADENOSYLTRANSFERASE 2,MAT 2, COMPND 6 METHIONINE ADENOSYLTRANSFERASE II,MAT-II; COMPND 7 EC: 2.5.1.6; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAT2A, AMS2, MATA2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS S-ADENOSYLMETHIONINE BIOSYNTHESIS, ALLOSTERIC INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHIMPL REVDAT 2 10-APR-24 8QE1 1 JRNL REVDAT 1 20-MAR-24 8QE1 0 JRNL AUTH S.J.ATKINSON,S.K.BAGAL,A.ARGYROU,S.ASKIN,T.CHEUNG, JRNL AUTH 2 E.CHIARPARIN,M.COEN,I.T.COLLIE,I.L.DALE,C.DE FUSCO, JRNL AUTH 3 K.DILLMAN,L.EVANS,L.J.FERON,A.J.FOSTER,M.GRONDINE,V.KANTAE, JRNL AUTH 4 G.M.LAMONT,S.LAMONT,J.T.LYNCH,S.NILSSON LILL,G.R.ROBB, JRNL AUTH 5 J.SAEH,M.SCHIMPL,J.S.SCOTT,J.SMITH,B.SRINIVASAN, JRNL AUTH 6 S.TENTARELLI,M.VAZQUEZ-CHANTADA,D.WAGNER,J.J.WALSH,D.WATSON, JRNL AUTH 7 B.WILLIAMSON JRNL TITL DEVELOPMENT OF A SERIES OF PYRROLOPYRIDONE MAT2A INHIBITORS. JRNL REF J.MED.CHEM. V. 67 4541 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38466661 JRNL DOI 10.1021/ACS.JMEDCHEM.3C01860 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (24-FEB-2021) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.5 REMARK 3 NUMBER OF REFLECTIONS : 137345 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.159 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.164 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 6899 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.11 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 34.58 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2600 REMARK 3 BIN R VALUE (WORKING SET) : 0.2181 REMARK 3 BIN FREE R VALUE : 0.2094 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.35 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 147 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2959 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 356 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.25460 REMARK 3 B22 (A**2) : 0.05600 REMARK 3 B33 (A**2) : -0.31060 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.110 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.031 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.030 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.030 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.029 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.966 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3098 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4202 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1085 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 525 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3098 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 395 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3363 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.99 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 5.16 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.56 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 26.0850 38.8371 32.3693 REMARK 3 T TENSOR REMARK 3 T11: -0.0010 T22: -0.0007 REMARK 3 T33: -0.0044 T12: -0.0039 REMARK 3 T13: -0.0016 T23: -0.0019 REMARK 3 L TENSOR REMARK 3 L11: 0.1403 L22: 0.2404 REMARK 3 L33: 0.1300 L12: -0.0781 REMARK 3 L13: 0.0127 L23: 0.0012 REMARK 3 S TENSOR REMARK 3 S11: -0.0038 S12: 0.0041 S13: -0.0178 REMARK 3 S21: -0.0146 S22: 0.0035 S23: 0.0250 REMARK 3 S31: 0.0155 S32: -0.0160 S33: 0.0003 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8QE1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1292133056. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 137345 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.095 REMARK 200 RESOLUTION RANGE LOW (A) : 55.294 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.7 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.14 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.31800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8-12 % PEG 8000, 8-12 % ETHYLENE REMARK 280 GLYCOL, 0.1 M HEPES PH 8.0, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.21100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.93850 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 58.30450 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.21100 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.93850 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 58.30450 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.21100 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 46.93850 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 58.30450 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.21100 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 46.93850 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.30450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 68.42200 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 93.87700 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 580 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 759 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 849 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 GLY A 3 REMARK 465 GLN A 4 REMARK 465 LEU A 5 REMARK 465 ASN A 6 REMARK 465 GLY A 7 REMARK 465 PHE A 8 REMARK 465 HIS A 9 REMARK 465 GLU A 10 REMARK 465 ALA A 11 REMARK 465 PHE A 12 REMARK 465 ILE A 13 REMARK 465 GLU A 14 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 15 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 226 -68.06 -108.55 REMARK 500 THR A 270 -99.24 -116.87 REMARK 500 ARG A 292 -60.23 -93.80 REMARK 500 TYR A 335 18.30 57.79 REMARK 500 ASP A 383 16.76 59.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 856 DISTANCE = 5.92 ANGSTROMS DBREF 8QE1 A 1 395 UNP P31153 METK2_HUMAN 1 395 SEQADV 8QE1 GLN A -1 UNP P31153 EXPRESSION TAG SEQADV 8QE1 SER A 0 UNP P31153 EXPRESSION TAG SEQRES 1 A 397 GLN SER MET ASN GLY GLN LEU ASN GLY PHE HIS GLU ALA SEQRES 2 A 397 PHE ILE GLU GLU GLY THR PHE LEU PHE THR SER GLU SER SEQRES 3 A 397 VAL GLY GLU GLY HIS PRO ASP LYS ILE CYS ASP GLN ILE SEQRES 4 A 397 SER ASP ALA VAL LEU ASP ALA HIS LEU GLN GLN ASP PRO SEQRES 5 A 397 ASP ALA LYS VAL ALA CYS GLU THR VAL ALA LYS THR GLY SEQRES 6 A 397 MET ILE LEU LEU ALA GLY GLU ILE THR SER ARG ALA ALA SEQRES 7 A 397 VAL ASP TYR GLN LYS VAL VAL ARG GLU ALA VAL LYS HIS SEQRES 8 A 397 ILE GLY TYR ASP ASP SER SER LYS GLY PHE ASP TYR LYS SEQRES 9 A 397 THR CYS ASN VAL LEU VAL ALA LEU GLU GLN GLN SER PRO SEQRES 10 A 397 ASP ILE ALA GLN GLY VAL HIS LEU ASP ARG ASN GLU GLU SEQRES 11 A 397 ASP ILE GLY ALA GLY ASP GLN GLY LEU MET PHE GLY TYR SEQRES 12 A 397 ALA THR ASP GLU THR GLU GLU CYS MET PRO LEU THR ILE SEQRES 13 A 397 VAL LEU ALA HIS LYS LEU ASN ALA LYS LEU ALA GLU LEU SEQRES 14 A 397 ARG ARG ASN GLY THR LEU PRO TRP LEU ARG PRO ASP SER SEQRES 15 A 397 LYS THR GLN VAL THR VAL GLN TYR MET GLN ASP ARG GLY SEQRES 16 A 397 ALA VAL LEU PRO ILE ARG VAL HIS THR ILE VAL ILE SER SEQRES 17 A 397 VAL GLN HIS ASP GLU GLU VAL CYS LEU ASP GLU MET ARG SEQRES 18 A 397 ASP ALA LEU LYS GLU LYS VAL ILE LYS ALA VAL VAL PRO SEQRES 19 A 397 ALA LYS TYR LEU ASP GLU ASP THR ILE TYR HIS LEU GLN SEQRES 20 A 397 PRO SER GLY ARG PHE VAL ILE GLY GLY PRO GLN GLY ASP SEQRES 21 A 397 ALA GLY LEU THR GLY ARG LYS ILE ILE VAL ASP THR TYR SEQRES 22 A 397 GLY GLY TRP GLY ALA HIS GLY GLY GLY ALA PHE SER GLY SEQRES 23 A 397 LYS ASP TYR THR LYS VAL ASP ARG SER ALA ALA TYR ALA SEQRES 24 A 397 ALA ARG TRP VAL ALA LYS SER LEU VAL LYS GLY GLY LEU SEQRES 25 A 397 CYS ARG ARG VAL LEU VAL GLN VAL SER TYR ALA ILE GLY SEQRES 26 A 397 VAL SER HIS PRO LEU SER ILE SER ILE PHE HIS TYR GLY SEQRES 27 A 397 THR SER GLN LYS SER GLU ARG GLU LEU LEU GLU ILE VAL SEQRES 28 A 397 LYS LYS ASN PHE ASP LEU ARG PRO GLY VAL ILE VAL ARG SEQRES 29 A 397 ASP LEU ASP LEU LYS LYS PRO ILE TYR GLN ARG THR ALA SEQRES 30 A 397 ALA TYR GLY HIS PHE GLY ARG ASP SER PHE PRO TRP GLU SEQRES 31 A 397 VAL PRO LYS LYS LEU LYS TYR HET U8E A 401 31 HET SAM A 402 27 HETNAM U8E 4-[4-[BIS(FLUORANYL)METHOXY]PHENYL]-3-CYCLOPROPYL-6-(4- HETNAM 2 U8E METHOXYPHENYL)-2~{H}-PYRAZOLO[4,3-B]PYRIDIN-5-ONE HETNAM SAM S-ADENOSYLMETHIONINE FORMUL 2 U8E C23 H19 F2 N3 O3 FORMUL 3 SAM C15 H22 N6 O5 S FORMUL 4 HOH *356(H2 O) HELIX 1 AA1 HIS A 29 ASP A 49 1 21 HELIX 2 AA2 ASP A 78 GLY A 91 1 14 HELIX 3 AA3 SER A 95 GLY A 98 5 4 HELIX 4 AA4 SER A 114 HIS A 122 1 9 HELIX 5 AA5 ASN A 126 ILE A 130 5 5 HELIX 6 AA6 PRO A 151 ASN A 170 1 20 HELIX 7 AA7 CYS A 214 LYS A 225 1 12 HELIX 8 AA8 PRO A 232 LEU A 236 5 5 HELIX 9 AA9 GLY A 253 ASP A 258 1 6 HELIX 10 AB1 LYS A 289 GLY A 308 1 20 HELIX 11 AB2 SER A 341 PHE A 353 1 13 HELIX 12 AB3 ARG A 356 ASP A 365 1 10 HELIX 13 AB4 ILE A 370 ALA A 375 5 6 HELIX 14 AB5 PHE A 385 VAL A 389 5 5 SHEET 1 AA1 4 THR A 17 VAL A 25 0 SHEET 2 AA1 4 LEU A 176 ASP A 191 -1 O TYR A 188 N PHE A 18 SHEET 3 AA1 4 ALA A 194 HIS A 209 -1 O ILE A 198 N GLN A 187 SHEET 4 AA1 4 ILE A 241 LEU A 244 1 O HIS A 243 N ILE A 203 SHEET 1 AA2 4 ASN A 105 GLU A 111 0 SHEET 2 AA2 4 MET A 64 THR A 72 1 N LEU A 67 O ALA A 109 SHEET 3 AA2 4 LYS A 53 LYS A 61 -1 N LYS A 61 O MET A 64 SHEET 4 AA2 4 GLY A 260 LEU A 261 -1 O GLY A 260 N ALA A 60 SHEET 1 AA3 2 ASP A 93 ASP A 94 0 SHEET 2 AA3 2 PHE A 99 ASP A 100 -1 O PHE A 99 N ASP A 94 SHEET 1 AA4 3 GLY A 136 THR A 143 0 SHEET 2 AA4 3 ARG A 313 TYR A 320 -1 O VAL A 316 N GLY A 140 SHEET 3 AA4 3 SER A 329 PHE A 333 -1 O PHE A 333 N LEU A 315 CRYST1 68.422 93.877 116.609 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014615 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010652 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008576 0.00000